Takeda Pharmaceutical Company Limited (TAK) Social Stream



Takeda Pharmaceutical Company Limited (TAK): $13.55

0.50 (+3.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

TAKEDA PHARMACEUTICAL CO LTD (TAK) Price Targets From Analysts

Use the tables below to see what analysts covering TAKEDA PHARMACEUTICAL CO LTD think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-06 3 $21 $17.6 $18.866 $13.16 43.36%
2021-12-08 3 $21 $15 $17.867 $13.16 35.77%
2022-01-16 3 $21 $15 $17.866 $13.16 35.76%
2022-02-23 3 $21 $15 $17.466 $13.16 32.72%
2022-05-12 3 $21 $16.4 $17.933 $13.16 36.27%
2022-05-30 3 $21 $16.4 $18.166 $13.16 38.04%
2022-07-29 3 $24 $13.8 $18.3 $13.16 39.06%
2022-08-14 3 $24 $13.8 $18.1 $13.16 37.54%
2022-09-17 3 $24 $13.8 $18 $13.16 36.78%

The Trend in the Analyst Price Target


TAK's average price target has moved up $0.07 over the prior 128 days.

Over the past 46 weeks, TAK's average upside potential has been 27.21%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-02-04 3 21 15.0 17.466 14.70 18.82%
2022-02-23 3 21 15.0 17.466 15.00 16.44%
2022-03-04 3 21 16.4 17.933 15.05 19.16%
2022-05-30 3 21 16.4 18.166 14.77 22.99%
2022-08-02 3 24 13.8 18.100 13.98 29.47%

TAK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.33 1 0 2 0 0 3

The Trend in the Broker Recommendations


Over the past 26 weeks, TAK's average broker recommendation rating improved by 0.67.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, TAKEDA PHARMACEUTICAL CO LTD's number of analysts covering the stock is higher than 100.3% of them.
  • In terms of how TAKEDA PHARMACEUTICAL CO LTD fares relative to stocks in the large market cap category, note that its average analyst price target is higher than 77.96% of that group.
  • TAKEDA PHARMACEUTICAL CO LTD's upside potential (average analyst target price relative to current price) is greater than 168.3% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, TAKEDA PHARMACEUTICAL CO LTD's variance in analysts' estimates is lower than -151.09% of them.

In the Pharmaceutical Products industry, SRPT, SNY, and RPRX are the three stocks most similar to TAKEDA PHARMACEUTICAL CO LTD regarding the price target and analyst recommendation information presented here.

Is TAK a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7232 seconds.